Patent Assignment
Reel/Frame 059358/0714
Reassignment and Release of Security Interest
Recorded: 2022-03-10
Pages: 14
Assignor
OXFORD FINANCE LLC
Executed: 2022-03-08
Assignee
XERIS PHARMACEUTICALS, INC.
180 NORTH LASALLE STREET, SUITE 1600, CHICAGO, ILLINOIS, 60601
Covered Properties
(8)
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Application:
16/600,722 →
Publication:
US 2020/0215162
Methods for Treating Congenital Hyperinsulinism
Application:
16/630,774 →
Publication:
US 2020/0147306
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Treatment of Exercise-Induced Hypoglycemia in Type 1 and Insulin Using Type 2 Diabetes
Application:
16/955,698 →
Publication:
US 2021/0008170
Treatment of Post-Bariatric Hypoglycemia Using Mini-Dose Stable Glucagon
Application:
16/964,124 →
Publication:
US 2021/0030847
Stable Formulations for Parenteral Injection of Peptide Drugs
Application:
17/215,449 →
Publication:
US 2021/0315961
Stable Sustained Release Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Application:
63/044,973 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 31, 2020
From: PRESTRELSKI, STEVEN; SANDOVAL, MICHAEL; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 052276/0012 →
Assignment of Assignor's Interest
Aug 12, 2020
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 053480/0851 →
Assignment of Assignor's Interest
Sep 29, 2020
From: CASSAVAUGH, EVAN; PRESTRELSKI, STEVEN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 053915/0648 →
Assignment of Assignor's Interest
Nov 2, 2020
From: PATTI, MARY-ELIZABETH
To: JOSLIN DIABETES CENTER, INC.
Reel/Frame 054245/0816 →
Assignment of Assignor's Interest
Nov 2, 2020
From: NEWSWANGER, BRETT; PRESTRELSKI, STEVEN J.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 054245/0626 →
Intellectual Property Security Agreement
May 4, 2021
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056135/0800 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Assignment of Assignor's Interest
Nov 10, 2022
From: DONOVAN, MARTIN; HU, WENDY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 061721/0694 →
Security Interest
Mar 5, 2024
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LTD.
To: HAYFIN SERVICES LLP
Reel/Frame 066647/0595 →
Assignment of Assignor's Interest
Aug 19, 2025
From: PRESTRELSKI, STEVEN J.; KINZELL, JOHN; NEWSWANGER, BRETT; THORNTON, PAUL
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 072061/0127 →
Change of Address
Aug 29, 2025
From: XERIS PHARMACEUTICALS, INC.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 072771/0247 →
Assignment of Assignor's Interest
Nov 24, 2025
From: PRESTRELSKI, STEVEN; NEWSWANGER, BRETT; CUMMINS, MARTIN; RIDDELL, MICHAEL
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 073022/0053 →